EMBC: Embecta Corp.
Performance
Watchlist
Select an item
Summary
EMBC at a glance
EMBC returned -51.99% over the past year. Its worst drop in that year was -79.64%, smaller than 2% of stocks on Redstone, and its Sharpe ratio of -0.40 beats 14% of stocks on Redstone. It yields 4.99%.
Current Drawdown
-54.77%
Rolling Volatility
51.96%
Dividends
EMBC dividends
Yield
4.99%
Paid, past year
$0.32
Pays
Quarterly
Growth a year
+26.0%
Per share, by year
Return over the past year
EMBC paid $0.32 a share over the past year, every quarter. Its yearly rate rose from $0.30 in 2022 to $0.60 in 2025, 26.0% a year. With dividends reinvested it returned -51.99% over the past year, against -53.52% on price alone.
›All 17 payments since Aug 25, 2022
- Aug 27, 2026$0.01
- May 28, 2026$0.01
- Feb 27, 2026$0.15
- Dec 5, 2025$0.15
- Aug 29, 2025$0.15
- May 28, 2025$0.15
- Feb 28, 2025$0.15
- Dec 6, 2024$0.15
- Aug 27, 2024$0.15
- May 24, 2024$0.15
- Feb 27, 2024$0.15
- Dec 1, 2023$0.15
- Aug 24, 2023$0.15
- May 25, 2023$0.15
- Feb 24, 2023$0.15
- Dec 29, 2022$0.15
- Aug 25, 2022$0.15
Metrics
Risk Indicators
Profile
About EMBC
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes.
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $363M
- Listed
- Mar 2022
- Employees
- 1,850
- Headquarters
- Parsippany, NJ
- Website
- embecta.com
Comparisons